BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201119T120000
DTEND;TZID=America/Vancouver:20201119T130000
DTSTAMP:20260810T211155
CREATED:20201103T214500Z
LAST-MODIFIED:20201103T214500Z
UID:11466-1605787200-1605790800@scienceinboston.com
SUMMARY:Dana Farber Targeted Protein Degradation Seminar: Dan Nomura
DESCRIPTION:Reimagining Druggability using Chemoproteomic Platforms\nWebinar registration: \nhttps://dfci.zoom.us/webinar/register/WN_IgnG5R2VSseCnikqf-v_1A \nHost: Breanna Zerfas \n\n\nDan Nomura\n\n\nDan Nomura is a professor in the Departments of Chemistry\, Molecular and Cell Biology\, and Nutritional Sciences and Toxicology at the University of California\, Berkeley. He is the director of the Novartis-Berkeley Center for Proteomics and Chemistry Technologies focused on using chemoproteomic platforms to tackle the undruggable proteome. Dr. Nomura is also the co-founder for Frontier Medicines. Dr. Nomura is an editor for Cell Chemical Biology. He earned his B.A. in Molecular and Cell Biology and Ph.D. in Molecular Toxicology with Professor John Casida at UC Berkeley and was a postdoctoral fellow at The Scripps Research Institute in chemical physiology with Professor Ben Cravatt before returning to UC Berkeley as a faculty member in 2011. Among his honors are selection as a Searle Scholar\, American Cancer Society Research Scholar Award\, and the Mark Foundation for Cancer Research ASPIRE Award.Research in the Nomura Research Group is focused on reimagining druggability using chemoproteomic platforms to discover new disease therapies. 
URL:https://scienceinboston.com/event/dana-farber-targeted-protein-degradation-seminar-dan-nomura/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201119T120000
DTEND;TZID=America/Vancouver:20201119T130000
DTSTAMP:20260810T211155
CREATED:20201103T214500Z
LAST-MODIFIED:20201103T214500Z
UID:27605-1605787200-1605790800@scienceinboston.com
SUMMARY:Dana Farber Targeted Protein Degradation Seminar: Dan Nomura
DESCRIPTION:Reimagining Druggability using Chemoproteomic Platforms\nWebinar registration: \nhttps://dfci.zoom.us/webinar/register/WN_IgnG5R2VSseCnikqf-v_1A \nHost: Breanna Zerfas \n\n\nDan Nomura\n\n\nDan Nomura is a professor in the Departments of Chemistry\, Molecular and Cell Biology\, and Nutritional Sciences and Toxicology at the University of California\, Berkeley. He is the director of the Novartis-Berkeley Center for Proteomics and Chemistry Technologies focused on using chemoproteomic platforms to tackle the undruggable proteome. Dr. Nomura is also the co-founder for Frontier Medicines. Dr. Nomura is an editor for Cell Chemical Biology. He earned his B.A. in Molecular and Cell Biology and Ph.D. in Molecular Toxicology with Professor John Casida at UC Berkeley and was a postdoctoral fellow at The Scripps Research Institute in chemical physiology with Professor Ben Cravatt before returning to UC Berkeley as a faculty member in 2011. Among his honors are selection as a Searle Scholar\, American Cancer Society Research Scholar Award\, and the Mark Foundation for Cancer Research ASPIRE Award.Research in the Nomura Research Group is focused on reimagining druggability using chemoproteomic platforms to discover new disease therapies. 
URL:https://scienceinboston.com/event/dana-farber-targeted-protein-degradation-seminar-dan-nomura-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR